NCT06406010 Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy
| NCT ID | NCT06406010 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Matias Vested |
| Condition | Anesthesia, Local |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-08-19 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 90 participants in total. It began in 2024-08-19 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).
Eligibility Criteria
Inclusion Criteria: 1. Patients ≥ 18 years old 2. Informed consent 3. Scheduled for periacetabular osteotomy under general anesthesia with intubation 4. American Society of Anesthesiologists (ASA) physical status classification I to III 5. Can read and understand Danish Exclusion Criteria: 1. Known allergy to ropivacaine 2. Daily use of opioids, gabapentin or tricyclic antidepressant (regardless of dose) within the last four weeks prior to surgery 3. Contraindications to Celocoxib, NSAIDs or paracetamol
Contact & Investigator
Matias Vested, Md, PhD
STUDY CHAIR
Rigshospitalet University of Copenhagen
Frequently Asked Questions
Who can join the NCT06406010 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anesthesia, Local. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06406010 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06406010 currently recruiting?
Yes, NCT06406010 is actively recruiting participants. Contact the research team at matias.vested@regionh.dk for enrollment information.
Where is the NCT06406010 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT06406010 clinical trial?
NCT06406010 is sponsored by Matias Vested. The principal investigator is Matias Vested, Md, PhD at Rigshospitalet University of Copenhagen. The trial plans to enroll 90 participants.